Мақаланы E-mail арқылы жіберу Adipogenic Differentiation of Human Mesenchymal Stem Cells Derived from Fetal Bone Marrow Using Rosiglitazone
- Авторлар: Revittser A.1, Neguliaev Y.1,2
-
Мекемелер:
- Department of Medical Physics, Peter the Great St. Petersburg Polytechnic University
- Institute of Cytology, Russian Academy of Sciences
- Шығарылым: Том 12, № 5 (2018)
- Беттер: 367-372
- Бөлім: Article
- URL: https://journals.rcsi.science/1990-519X/article/view/212745
- DOI: https://doi.org/10.1134/S1990519X18050061
- ID: 212745
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
Protocols of adipogenic differentiation for mesenchymal stem cells (MSC) are mostly based on addition of various inducers, including rosiglitazone, a. specific agonist of PPARG facilitated the differentiation in this lineage. Rosiglitazone was not used for induction of adipogenic differentiation of fetal MSC from bone marrow (fMSC-BM). Here we described adipogenic differentiation induced by rosiglitazone in fMSC-BM (FetMSC). We found that the number of differentiated cells was 31.0 ± 1.9% (Oil Red O staining n = 1121). Expression of PPARG gene, a key adipogenic regulator, increased during differentiation. It is demonstrated that fMSC-BM generated adipocytes in the differentiation medium with rosiglitazone.
Авторлар туралы
A. Revittser
Department of Medical Physics, Peter the Great St. Petersburg Polytechnic University
Хат алмасуға жауапты Автор.
Email: eetytnet@gmail.com
Ресей, St. Petersburg, 195251
Yu. Neguliaev
Department of Medical Physics, Peter the Great St. Petersburg Polytechnic University; Institute of Cytology, Russian Academy of Sciences
Email: eetytnet@gmail.com
Ресей, St. Petersburg, 195251; St. Petersburg, 194064
